Evidence map›Paper›PMID 33375253›Full record

ArticleInternational journal of molecular sciences2020

Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities.

Lucía Pérez-Roque, Elena Núñez-Gómez, Alicia Rodríguez-Barbero, Carmelo Bernabéu, José M López-Novoa, Miguel Pericacho

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Placental Development and Pregnancy-Associated Diseases.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2022
    Review
  12. High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging.Journal of cardiovascular development and disease · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lucía Pérez-RoqueInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
Elena Núñez-GómezInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
Alicia Rodríguez-BarberoInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
Carmelo BernabéuCentro de Investigaciones Biológicas Margarita Salas, Consejo Superior de Investigaciones Científicas (CSIC) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.ORCID 0000-0002-1563-6162
José M López-NovoaInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.ORCID 0000-0002-6211-7269
Miguel PericachoInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.ORCID 0000-0003-0226-482X
Universidad de Salamanca · ESConsejo Superior de Investigaciones Científicas · ES

Funding

Consejo Superior de Investigaciones Científicas 201920E022Instituto de Salud Carlos III PI16/00460Instituto de Salud Carlos III PI19/01630Junta de Castilla y León GR100Kidney Research Network REDINREN RD016/0009/0025Kidney Research Network REDINREN RD06/0016/0013Kidney Research Network REDINREN RD12/0021/0032Ministerio de Economía y Competitividad SAF2010-15881Ministerio de Economía y Competitividad SAF2013-45784-R
6 · The paper itself

Abstract

Preeclampsia is a pregnancy-specific disease of high prevalence characterized by the onset of hypertension, among other maternal or fetal signs. Its etiopathogenesis remains elusive, but it is widely accepted that abnormal placentation results in the release of soluble factors that cause the clinical manifestations of the disease. An increased level of soluble endoglin (sEng) in plasma has been proposed to be an early diagnostic and prognostic biomarker of this disease. A pathogenic function of sEng involving hypertension has also been reported in several animal models with high levels of plasma sEng not directly dependent on pregnancy. The aim of this work was to study the functional effect of high plasma levels of sEng in the pathophysiology of preeclampsia in a model of pregnant mice, in which the levels of sEng in the maternal blood during pregnancy replicate the conditions of human preeclampsia. Our results show that wild type pregnant mice carrying human sEng-expressing transgenic fetuses (f

Indexed as

AnimalsEndoglinFemaleFetal Growth RetardationHumansMaleMiceMice, Inbred C57BLMice, Inbred CBAPlacenta DiseasesPre-EclampsiaPregnancyTrophoblastsVascular DiseasesEndoglinENG protein, humanmurine modelplacentapreeclampsiasoluble endoglin

Identifiers

PMID33375253
PMCPMC7795873
OpenAlexW3114573136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.